Synlett
DOI: 10.1055/a-2535-1306
account
Small Molecules in Medicinal Chemistry

Bioactive Molecules via Morita–Baylis–Hillman Chemistry

Ch. N. S. Sai Pavan Kumar
b   Department of Chemistry, School of Applied Science and Humanities, Vignan’s Foundation for Science, Technology and Research, Vadlamudi, Guntur 522213, Andhra Pradesh, India
c   Department of Chemistry, Vignan Degree & P.G. College, Palakaluru Road, Guntur 520 009, Andhra Pradesh, India
,
Vaidya Rao Jayathirtha
a   Organic Synthesis and Process Chemistry Department, AcSIR-Ghaziabad, CSIR-Indian Institute of Chemical Technology, Uppal Road Tarnaka, Hyderabad – 500007, Telangana, India
› Author Affiliations


Abstract

Morita–Baylis–Hillman (MBH) chemistry was applied to the synthesis of a variety of new chemical entities and their bioactivity was evaluated. Various substances synthesized via MBH chemistry have: antimalarial, anti-inflammatory, antidiabetic, antimicrobial, antitubercular, and anticancer activity and also act as phosphodiesterase inhibitors. There are a few instances animal model and biology studies explored. Several hits and lead molecules are identified and their IC50 values listed. The simplicity of Morita–Baylis–Hillman chemistry provides a realistic, impactful option for the pharma industry.

1 Introduction

2 Antimalarial Activity

3 Anti-inflammatory Activity of MBH Adducts Coupled to Heterocycles

4 Antidiabetic Activity of Epalrestat Analogues Derived from MBH Adducts

5 Antimicrobial Activity

6 Antitubercular Activity of N-Cinnamyl-isatins

7 Inhibitors of Phosphodiesterase-3 (PDE3); Cardiotonic Agents

8 Anticancer Activity

9 Asymmetric Morita–Baylis–Hillman Reactions

10 Conclusion



Publication History

Received: 11 December 2024

Accepted after revision: 07 February 2025

Accepted Manuscript online:
07 February 2025

Article published online:
07 April 2025

© 2025. Thieme. All rights reserved

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany